Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical
Oramed leverages its strategic capital markets expertise to support Alpha [...]
Intensity Therapeutics, Inc. Announces $2.35 Million Public Offering
The Series B-1 warrants will have an exercise price of [...]
Overture Life Secures $57M in Total Funding | Earns U.S. CLIA License to Deliver Reliable, Scalable IVF Automation
Overwater Ventures, GV, and Khosla Ventures invest in a rigorous [...]
Phantom Neuro Secures $19M Series A Funding
Investment will accelerate clinical trials and commercialization of Phantom X, [...]
Xeltis Successfully Passes Evaluation Phase for €10Mil Investment from European Innovation Council
Funding to support commercialization of its groundbreaking bioresorbable vascular conduits [...]
BDD Pharma Opens Brand New GMP Manufacturing Facility Following £2m In Funding
The BDD facility will provide cost-effective manufacturing and clinical testing [...]
Solace Raises $60M Series B | To Establish Healthcare Advocacy as New Standard of Care
This raise reflects accelerating market conviction that healthcare advocacy is [...]
OrganOx Completes $142 Million Equity Financing Led by HealthQuest Capital
The oversubscribed round was led by new investor HealthQuest Capital [...]
Advancing Eye Health: Perceive Pharma Secures $15M Investment Boost
In addition, Perceive Pharma announced that Carol Gallagher, Pharm.D. has [...]
Exero Medical Closes on $12.7M Preferred Seed Financing
This financing includes investments from new investors Longevity Venture Partners, [...]